Bioengineered in vitro models of thrombosis: Methods and techniques

Yu Shrike Zhang, Rahmi Oklu, Hassan Albadawi

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Thrombosis is a prevailing vascular disorder that has been historically studied in vivo with conventional animal models. Here we review recent advances in methods and techniques that allow for engineering of biomimetic in vitro models of thrombosis, usually combined with microfluidic devices, termed thrombosis-on-a-chip systems, to reproduce such vascular pathology outside living organisms. These human cell-based thrombosis-on-a-chip platforms recapitulate the important characteristics of native thrombosis in terms of vascular structures, extracellular matrix properties, cellular composition, and pathophysiology, making them enabling in vitro models to study this important class of vascular disorders as well as to develop personalized treatment regimens.

Original languageEnglish (US)
Pages (from-to)S329-S335
JournalCardiovascular Diagnosis and Therapy
Volume7
DOIs
StatePublished - Dec 1 2017

Fingerprint

Thrombosis
Blood Vessels
Lab-On-A-Chip Devices
Biomimetics
Extracellular Matrix
Animal Models
In Vitro Techniques
Pathology

Keywords

  • Bioprinting
  • Blood vessels
  • Interventional radiology
  • Soft lithography
  • Thrombosis
  • Thrombosis-on-a-chip

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Bioengineered in vitro models of thrombosis : Methods and techniques. / Zhang, Yu Shrike; Oklu, Rahmi; Albadawi, Hassan.

In: Cardiovascular Diagnosis and Therapy, Vol. 7, 01.12.2017, p. S329-S335.

Research output: Contribution to journalReview article

@article{0885ee30cab145f5bf12fef664a84ffc,
title = "Bioengineered in vitro models of thrombosis: Methods and techniques",
abstract = "Thrombosis is a prevailing vascular disorder that has been historically studied in vivo with conventional animal models. Here we review recent advances in methods and techniques that allow for engineering of biomimetic in vitro models of thrombosis, usually combined with microfluidic devices, termed thrombosis-on-a-chip systems, to reproduce such vascular pathology outside living organisms. These human cell-based thrombosis-on-a-chip platforms recapitulate the important characteristics of native thrombosis in terms of vascular structures, extracellular matrix properties, cellular composition, and pathophysiology, making them enabling in vitro models to study this important class of vascular disorders as well as to develop personalized treatment regimens.",
keywords = "Bioprinting, Blood vessels, Interventional radiology, Soft lithography, Thrombosis, Thrombosis-on-a-chip",
author = "Zhang, {Yu Shrike} and Rahmi Oklu and Hassan Albadawi",
year = "2017",
month = "12",
day = "1",
doi = "10.21037/cdt.2017.08.08",
language = "English (US)",
volume = "7",
pages = "S329--S335",
journal = "Cardiovascular Diagnosis and Therapy",
issn = "2223-3652",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Bioengineered in vitro models of thrombosis

T2 - Methods and techniques

AU - Zhang, Yu Shrike

AU - Oklu, Rahmi

AU - Albadawi, Hassan

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Thrombosis is a prevailing vascular disorder that has been historically studied in vivo with conventional animal models. Here we review recent advances in methods and techniques that allow for engineering of biomimetic in vitro models of thrombosis, usually combined with microfluidic devices, termed thrombosis-on-a-chip systems, to reproduce such vascular pathology outside living organisms. These human cell-based thrombosis-on-a-chip platforms recapitulate the important characteristics of native thrombosis in terms of vascular structures, extracellular matrix properties, cellular composition, and pathophysiology, making them enabling in vitro models to study this important class of vascular disorders as well as to develop personalized treatment regimens.

AB - Thrombosis is a prevailing vascular disorder that has been historically studied in vivo with conventional animal models. Here we review recent advances in methods and techniques that allow for engineering of biomimetic in vitro models of thrombosis, usually combined with microfluidic devices, termed thrombosis-on-a-chip systems, to reproduce such vascular pathology outside living organisms. These human cell-based thrombosis-on-a-chip platforms recapitulate the important characteristics of native thrombosis in terms of vascular structures, extracellular matrix properties, cellular composition, and pathophysiology, making them enabling in vitro models to study this important class of vascular disorders as well as to develop personalized treatment regimens.

KW - Bioprinting

KW - Blood vessels

KW - Interventional radiology

KW - Soft lithography

KW - Thrombosis

KW - Thrombosis-on-a-chip

UR - http://www.scopus.com/inward/record.url?scp=85038608993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038608993&partnerID=8YFLogxK

U2 - 10.21037/cdt.2017.08.08

DO - 10.21037/cdt.2017.08.08

M3 - Review article

AN - SCOPUS:85038608993

VL - 7

SP - S329-S335

JO - Cardiovascular Diagnosis and Therapy

JF - Cardiovascular Diagnosis and Therapy

SN - 2223-3652

ER -